DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ursodeoxycholic acid
Ursodeoxycholic acid
Label (PDF)
Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients
An Update on the Management of Cholestatic Liver Diseases
TRANSPARENCY COMMITTEE Opinion 19 February 2014
Estonian Statistics on Medicines 2016 1/41
Obeticholic Acid and 46% of the 5–10 Mg Group
Cow Dung Powder Poisoning
Alphabetical Listing of ATC Drugs & Codes
Anti-Tuberculosis Drug Induced Liver Injury and Ursodeoxycholic Acid
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases 1 2 3 4 5 Keith D
Non-Acetaminophen-Induced Acute Liver Failure
Therapy of Nonalcoholic Steatohepatitis (NASH) – Antioxidants and Cytoprotective Agents
Estonian Statistics on Medicines 2013 1/44
Obeticholic Acid (Ocaliva) Reference Number: ERX.SPA.174 Effective Date: 01.11.17 Last Review Date: 11.17 Revision Log
Obeticholic Acid (OCA)
List of New Drugs Approved in the Year 2020 Till Date
I (Acts Whose Publication Is Obligatory) COMMISSION
Top View
Biliary Bile Acids of Bears, Pandas, and Related Carnivores
New Therapies Postgrad Med J: First Published As 10.1136/Pgmj.73.856.75 on 1 February 1997
Ursodiol Use Is Possibly Associated with Lower Incidence of Hepatocellular Carcinoma in Hepatitis C Virus–Associated Liver Cirrhosis
OCALIVA (Obeticholic Acid)
Changes in Glutathione Content in Liver Diseases: an Update
Novel Modulation of Adenylyl Cyclase Type 2 Jason Michael Conley Purdue University
Obeticholic Acid: First Global Approval
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Effectiveness of Ursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis with Ulcerative Colitis: a Pediatric Case
Marrakesh Agreement Establishing the World Trade Organization
Future Medical Treatment of PSC
Treatment with Milk Thistle Extract (Silybum Marianum
Obeticholic Acid (Ocaliva®) Policy #: Rx.01.186
Ocaliva (Obeticholic Acid) Prior Authorization with Quantity Limit
Retrospective Comparison of 'Cheno' and 'Urso' in the Medical
Functional Disorders in the Sphincter of Oddi and Possibly Reflux-Associated Diseases in the Hepato-Biliary-Cholecysto-Pancreat
Downloaded from the Protein Data Bank (PDB ID: 6VSB)
Primary Biliary Cholangitis (PBC) & Ursodeoxycholic Acid (UDCA)
Protective Effects of Ursodeoxycholic Acid on Valproic
Treatment Regimens for Non-Alcoholic Fatty Liver Disease
(12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
NATIONAL INSTITUTE for HEALTH and CARE EXCELLENCE Centre for Clinical Practice – Surveillance Programme
(12) United States Patent (10) Patent No.: US 6,407,073 B1 Trkovnik Et Al
(12) United States Patent (10) Patent No.: US 9,642,809 B2 Hemmingsen Et Al
Efficacy of Ursodeoxycholic Acid in Nonalcoholic
205750Orig1s000
Ocaliva (Obeticholic Acid) NOTICE
Prescribing Pattern of Drugs in Patients with Alcoholic Liver Disease in a Tertiary Care Teaching Hospital
Pharmacy Medical Necessity Guidelines: Ocalivatm (Obeticholic Acid) Effective: November 10, 2020
Resolution Ap (2000) 1
Hepatic Lipidosis, the Liver Shadow of Neonates Fig 15.2 | Yellow Urates
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Clinical Efficacy of Diammonium Glycyrrhizinate on Drug Induced Liver Injury and Influence on Related Inflammatory Factors
(12) Patent Application Publication (10) Pub. No.: US 2011/0117194A1 Kim Et Al
Comparison Between Ursodeoxycholic Acid and Silymarin in Anticonvulsive Drugs Induced Hypertransaminasemia